BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21565479)

  • 41. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus.
    De Ferranti SD; Osganian SK
    Diab Vasc Dis Res; 2007 Dec; 4(4):285-96. PubMed ID: 18158698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity and hypertension: It's about more than the numbers.
    Ferdinand KC
    Obesity (Silver Spring); 2013 Apr; 21(4):657-8. PubMed ID: 23512315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of hypertension in children and adolescents with the metabolic syndrome.
    Puri M; Flynn JT
    J Cardiometab Syndr; 2006; 1(4):259-68. PubMed ID: 17679805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Medical management of primary nonalcoholic fatty liver disease].
    Moreno Sánchez D
    Med Clin (Barc); 2005 Jun; 125(3):108-16. PubMed ID: 15989845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Complex dietary measures and pharmacotherapy for metabolic syndrome].
    Pfeiffer AF; Kohl A
    Internist (Berl); 2007 Feb; 48(2):164-72. PubMed ID: 17268786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of the Metabolic Syndrome and the Obese Patient with Metabolic Disturbances: South Asian Perspective.
    Misra A; Bhardwaj S
    Nestle Nutr Inst Workshop Ser; 2015; 82():61-73. PubMed ID: 26544194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pediatric metabolic syndrome: a growing threat.
    Celik T; Iyisoy A; Yuksel UC
    Int J Cardiol; 2010 Jul; 142(3):302-3. PubMed ID: 19097654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic syndrome: a clinical and molecular perspective.
    Moller DE; Kaufman KD
    Annu Rev Med; 2005; 56():45-62. PubMed ID: 15660501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging drugs for non-alcoholic steatohepatitis.
    Tomeno W; Yoneda M; Imajo K; Ogawa Y; Kessoku T; Saito S; Eguchi Y; Nakajima A
    Expert Opin Emerg Drugs; 2013 Sep; 18(3):279-90. PubMed ID: 23848366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Obesity and the metabolic syndrome in children and adolescents].
    Knerr I
    MMW Fortschr Med; 2004 Aug; 146(33-34):41-3. PubMed ID: 15526625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Obesity in childhood].
    Shcherbakova MIu; Poriagina GI; Kovaleva EA
    Eksp Klin Gastroenterol; 2010; (7):74-83. PubMed ID: 21033087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exercise and the liver: implications for therapy in fatty liver disorders.
    Johnson NA; Keating SE; George J
    Semin Liver Dis; 2012 Feb; 32(1):65-79. PubMed ID: 22418889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physical activity and abdominal obesity in youth.
    Kim Y; Lee S
    Appl Physiol Nutr Metab; 2009 Aug; 34(4):571-81. PubMed ID: 19767790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical effectiveness of metformin and ramipril combination in complex therapy of patients with metabolic syndrome].
    Savchenko LH; Kaĭdasheva EI; Kutsenko LO; Kutsenko NL; Hordyns'ka IL; Mamontova TV; Markina TM; Kaĭdashev IP
    Lik Sprava; 2013; (1):109-17. PubMed ID: 23951921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity, Diabetes and Cardiovascular Diseases in India: Public Health Challenges.
    Shrivastava U; Misra A; Mohan V; Unnikrishnan R; Bachani D
    Curr Diabetes Rev; 2017; 13(1):65-80. PubMed ID: 27515855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Global "epidemics" of diabetes. Physical inactivity and obesity have direct connection to the increase--insulin resistance also among children and adolescents].
    Sjöholm A
    Lakartidningen; 2002 Mar; 99(10):1042-3. PubMed ID: 12024776
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children.
    Lavine JE; Schwimmer JB
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):129-30. PubMed ID: 16456401
    [No Abstract]   [Full Text] [Related]  

  • 58. The role of pharmacotherapy in the prevention and treatment of paediatric metabolic syndrome--Implications for long-term health: part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Sabin MA; Magnussen CG; Juonala M; Cowley MA; Shield JP
    Pharmacol Res; 2012 Apr; 65(4):397-401. PubMed ID: 22037094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of exercise and diet on chronic disease.
    Roberts CK; Barnard RJ
    J Appl Physiol (1985); 2005 Jan; 98(1):3-30. PubMed ID: 15591300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Obesity in adolescents: physical correlated pathologies, and therapeutic state of art].
    Giorgi PL
    Recenti Prog Med; 2007 Feb; 98(2):97-111. PubMed ID: 17439070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.